3.15BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04390B1052
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.28
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.51
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
390,603,008
Gross Profit TTM
354,927,008
EBITDA
-1,044,163,008
Profit Margin
-296.77%
Return On Assets TTM
-22.77%
Return On Equity TTM
-159.65%
Revenue Per Share TTM
1.195
Qtly Revenue Growth YOY
-71.60%
Diluted Eps TTM
-0.51
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
8.0729
Price Book MRQ
33.368
Enterprise Value Revenue
48
Enterprise Value EBITDA
0
310.01
2.02%778.94
1.79%438.38
1.55%24.64
1.13%319.52
0.23%154.28
0.18%164.04
0.11%88.30
-10.98%312.84
-1.20%755.43
-1.02%